effect of carboxypeptidase N on small cell lung carcinoma cells
Read Online

effect of carboxypeptidase N on small cell lung carcinoma cells by Eric Portelance

  • 690 Want to read
  • ·
  • 11 Currently reading

Published by Laurentian University in Sudbury, Ont .
Written in English

Book details:

Edition Notes

Statementby Eric Portelance.
The Physical Object
Pagination48 l. :
Number of Pages48
ID Numbers
Open LibraryOL22161710M

Download effect of carboxypeptidase N on small cell lung carcinoma cells


  Introduction. Lung cancer results in approximately , deaths per year, with a majority of these stemming from non–small-cell lung cancer (NSCLC; ref. 1).NSCLC has a poor Cited by: Although the inhibitory effect of parthenolide on NF-κB activity has been reported previously in several cancer cell lines [28–31], its significance, detailed mechanism and potential use in treatment and as an adjuvant with chemotherapy have not yet been fully investigated in human non-small cell lung cancer Cited by:   Non small cell lung cancer is the most common lung cancer, accounting for about 85% of all cases. NSCLC has three main types designated by the type of cells found in the tumor. They are: Adenocarcinomas: They are the most common type of NSCLC and account for about 40% of lung cancer . Small-cell carcinoma is a type of highly malignant cancer that most commonly arises within the lung, although it can occasionally arise in other body sites, such as the cervix, prostate, and gastrointestinal tract. Compared to non-small cell carcinoma, small cell carcinoma Specialty: Oncology.

Early phase clinical trials examined the efficacy of a platinum complex with etoposide and vinorelbine in non‐small cell lung cancer In these early studies, the platinum complex and etoposide were . Continued Small-Cell Lung Cancer Symptoms. Persons with small-cell lung cancer typically have had symptoms for a relatively short time (8 to 12 weeks) before they visit their doctor. Researchers observed non-small cell lung cancer cells containing an EGFR mutation, to see what effect vitamin D3 may have.   The cells were treated with hydroxyvitamin D3—the breakdown product of the vitamin which circulates in the blood. It was found that in this setting vitamin D3 inhibited the growth of lung cancer cells. Non-small cell lung cancer (NSCLC) is composed of three types of cancers that originate from lung tissue. The three types are known as adenocarcinomas, squamous cell carcinomas, and large cell carcinomas. Adenocarcinomas are slow-growing cancers that usually first appear in the peripheral or outside areas of the lungs; it occurs more often in smokers, but it's the most common type of lung.

Our study revealed that CPA4 expression was higher in both lung cancer cells and tumor tissues. We performed 3-(4,5-dimethylthiazolyl)-2,5-diphenyl tetrazolium bromide assays, colony-formation assays, and Cellomics ArrayScan Infinity analysis to demonstrate that CPA4 knockdown inhibited non small-cell lung cancer (NSCLC) cell .   Small cell lung cancer is a very aggressive form of lung cancer. Learn about small cell lung cancer symptoms, risk factors, diagnosis, and treatment.   The combination of Disulfiram and copper were capable of reducing lung cancer stem cells using ALDH as a marker. 2. Materials and methods Cell lines and materials. Non-small cell lung cancer .   It seems that all has to do with the facts behind the thyme. Then in made research on thyme. They invetigated the oils used as an A lung cancer cell exterminator, MCF-7 breast cancer cell, and PC-3 prostate cancer cells, and then found that thyme essential oil was the strongest oil containing cancer-cell .